172 related articles for article (PubMed ID: 10652986)
1. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.
Bassett CN; Neely MD; Sidell KR; Markesbery WR; Swift LL; Montine TJ
Lipids; 1999 Dec; 34(12):1273-80. PubMed ID: 10652986
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid lipoproteins in Alzheimer's disease.
Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ
Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.
Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ
J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015
[TBL] [Abstract][Full Text] [Related]
4. Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules.
Neely MD; Swift LL; Montine TJ
Lipids; 2000 Nov; 35(11):1249-57. PubMed ID: 11132184
[TBL] [Abstract][Full Text] [Related]
5. Lipoproteins and lipid peroxidation in Alzheimer's disease.
Bassett CN; Montine TJ
J Nutr Health Aging; 2003; 7(1):24-9. PubMed ID: 12679837
[TBL] [Abstract][Full Text] [Related]
6. Increased lipoprotein oxidation in Alzheimer's disease.
Schippling S; Kontush A; Arlt S; Buhmann C; Stürenburg HJ; Mann U; Müller-Thomsen T; Beisiegel U
Free Radic Biol Med; 2000 Feb; 28(3):351-60. PubMed ID: 10699746
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E in neurodegenerative disorders: Alzheimer's disease.
Kontush K; Schekatolina S
Ann N Y Acad Sci; 2004 Dec; 1031():249-62. PubMed ID: 15753151
[TBL] [Abstract][Full Text] [Related]
8. In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane)dihydrochloride (AAPH) or Fe(2+)/H(2)O(2): insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders.
Joshi G; Perluigi M; Sultana R; Agrippino R; Calabrese V; Butterfield DA
Neurochem Int; 2006 Mar; 48(4):318-27. PubMed ID: 16386335
[TBL] [Abstract][Full Text] [Related]
9. Time-course of oxidation of lipids in human cerebrospinal fluid in vitro.
Arlt S; Finckh B; Beisiegel U; Kontush A
Free Radic Res; 2000 Feb; 32(2):103-14. PubMed ID: 10653481
[TBL] [Abstract][Full Text] [Related]
10. Controversial alkoxyl and peroxyl radical scavenging activity of the tryptophan metabolite 3-hydroxy-anthranilic acid.
Dorta E; Aspée A; Pino E; González L; Lissi E; López-Alarcón C
Biomed Pharmacother; 2017 Jun; 90():332-338. PubMed ID: 28376401
[TBL] [Abstract][Full Text] [Related]
11. CSF lipoproteins and Alzheimer's disease.
Neely MD; Montine TJ
J Nutr Health Aging; 2002; 6(6):383-91. PubMed ID: 12459889
[TBL] [Abstract][Full Text] [Related]
12. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation.
Belinky PA; Aviram M; Fuhrman B; Rosenblat M; Vaya J
Atherosclerosis; 1998 Mar; 137(1):49-61. PubMed ID: 9568736
[TBL] [Abstract][Full Text] [Related]
13. Lipid peroxidation in aging brain and Alzheimer's disease.
Montine TJ; Neely MD; Quinn JF; Beal MF; Markesbery WR; Roberts LJ; Morrow JD
Free Radic Biol Med; 2002 Sep; 33(5):620-6. PubMed ID: 12208348
[TBL] [Abstract][Full Text] [Related]
14. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins.
Hazell LJ; Davies MJ; Stocker R
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms.
Faure P; Oziol L; Artur Y; Chomard P
Biochimie; 2004 Jun; 86(6):411-8. PubMed ID: 15283976
[TBL] [Abstract][Full Text] [Related]
16. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
[TBL] [Abstract][Full Text] [Related]
17. Formation of the aldehydic choline glycerophospholipids in human red blood cell membrane peroxidized with an azo initiator.
Kawai Y; Ogamo A; Nakagawa Y
J Biochem; 1999 Jul; 126(1):115-20. PubMed ID: 10393328
[TBL] [Abstract][Full Text] [Related]
18. Application of water-soluble radical initiator, 2,2'-azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride, to a study of oxidative stress.
Yoshida Y; Itoh N; Saito Y; Hayakawa M; Niki E
Free Radic Res; 2004 Apr; 38(4):375-84. PubMed ID: 15190934
[TBL] [Abstract][Full Text] [Related]
19. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL.
Hussein O; Schlezinger S; Rosenblat M; Keidar S; Aviram M
Atherosclerosis; 1997 Jan; 128(1):11-8. PubMed ID: 9051193
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant paradoxes of phenolic compounds: peroxyl radical scavenger and lipid antioxidant, etoposide (VP-16), inhibits sarcoplasmic reticulum Ca(2+)-ATPase via thiol oxidation by its phenoxyl radical.
Ritov VB; Goldman R; Stoyanovsky DA; Menshikova EV; Kagan VE
Arch Biochem Biophys; 1995 Aug; 321(1):140-52. PubMed ID: 7639514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
